Liquidia
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · North Carolina, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
419 Davis Dr Ste 100, Morrisville, North...Phone Number
(919) 328-4400Website
www.liquidia.comRevenue
$158.3 MillionStock Symbol
LQDAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Liquidia
Liquidia Technologies, Inc., a wholly owned subsidiary of Liquidia Corporation, is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. Liquidia is headquartered in Research Triangle Park, NC.Explore more
Liquidia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Liquidia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Liquidia
Liquidia, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Liquidia has new funding data
Product Launch: Get notified when Liquidia launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Liquidia had a recent Job posting/layoffs
Earning: See what the market has to say on Liquidia recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Liquidia has recently received funding, and reach out quickly before it becomes old news!
Check out if Liquidia is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Liquidia as Masked Content
Find more new buyers
Compare Similar Companies to Liquidia
Compare insights from companies similar to Liquidia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Liquidia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Liquidia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Liquidia.
Liquidia financials insights
Gather financial insights about Liquidia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series A
$6M
2007
Series B
$16M
2010
Series C
$25M
2018
Series D
$25.5M
2021
Debt
$20.5M
2022
Debt
$40M
2025
Debt
$100M
Liquidia Tech Stack
A closer look at the technologies used by Liquidia
Most Recent Scoops
Person-Based
Earnings, Stake & Stock Ownership, Finance
Person-Based
Pharmaceuticals
Person-Based
Sales, Doctors / Physicians
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Liquidia News & Media
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
Liquidia CEO Roger Jeffs and COO/CFO Michael Kaseta will present at the Jefferies Global Healthcare Conference on June 3, 2026, at 12:45 p.m. ET.Liquidia Corporation (LQDA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Liquidia Corporation (LQDA) Bank of America Global Healthcare Conference 2026 May 13, 2026 11:40 AM EDTCompany ParticipantsMichael Kaseta - COO &...What to Know About This Fund’s $15.5 Million Sale of Liquidia as Shares Skyrocket Nearly 260%
Liquidia develops therapies for rare cardiopulmonary diseases, leveraging proprietary drug delivery technologies in the U.S. market.Liquidia Corporation (LQDA) Q1 2026 Earnings Call Transcript
Liquidia Corporation (LQDA) Q1 2026 Earnings Call May 11, 2026 8:30 AM EDTCompany ParticipantsJason Adair - Chief Business OfficerRoger Jeffs - CEO &...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Liquidia
Sign Up For FreeTo access detailed company insights
Liquidia Technologies, Inc., a wholly owned subsidiary of Liquidia Corporation, is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of... Read More
